CareDx, Inc (CDNA)
USD 15.0
(-0.46%)
USD 15.0
(-0.46%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 28.27 Million USD | -15.35% |
| 2022 | 33.4 Million USD | 92.05% |
| 2021 | 17.39 Million USD | 8.25% |
| 2020 | 16.06 Million USD | 578.02% |
| 2019 | 2.37 Million USD | -77.37% |
| 2018 | 10.47 Million USD | -42.89% |
| 2017 | 18.33 Million USD | 1570.13% |
| 2016 | 1.09 Million USD | -91.48% |
| 2015 | 12.88 Million USD | 136.42% |
| 2014 | 5.45 Million USD | -50.05% |
| 2013 | 10.91 Million USD | -18.61% |
| 2012 | 13.41 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 25.38 Million USD | 0.0% |
| 2024 Q3 | 23.84 Million USD | 0.0% |
| 2024 Q1 | 26.89 Million USD | 0.0% |
| 2023 Q1 | 32 Million USD | -4.19% |
| 2023 Q3 | 29.25 Million USD | -4.37% |
| 2023 Q2 | 30.58 Million USD | -4.43% |
| 2023 FY | 28.27 Million USD | -15.35% |
| 2023 Q4 | 28.27 Million USD | -3.33% |
| 2022 Q2 | 16.06 Million USD | -3.97% |
| 2022 Q1 | 16.72 Million USD | -3.82% |
| 2022 FY | 33.4 Million USD | 92.05% |
| 2022 Q4 | 33.4 Million USD | -3.75% |
| 2022 Q3 | 34.7 Million USD | 116.05% |
| 2021 Q4 | 17.39 Million USD | -2.7% |
| 2021 Q2 | 17.78 Million USD | -3.68% |
| 2021 Q3 | 17.87 Million USD | 0.52% |
| 2021 FY | 17.39 Million USD | 8.25% |
| 2021 Q1 | 18.46 Million USD | 14.89% |
| 2020 Q2 | 17.02 Million USD | -2.73% |
| 2020 FY | 16.06 Million USD | 578.02% |
| 2020 Q4 | 16.06 Million USD | -2.84% |
| 2020 Q1 | 17.5 Million USD | 638.52% |
| 2020 Q3 | 16.53 Million USD | -2.85% |
| 2019 Q2 | 2.12 Million USD | -18.39% |
| 2019 Q4 | 2.37 Million USD | 62.55% |
| 2019 FY | 2.37 Million USD | -77.37% |
| 2019 Q3 | 1.45 Million USD | -31.26% |
| 2019 Q1 | 2.59 Million USD | -75.18% |
| 2018 Q4 | 10.47 Million USD | -21.75% |
| 2018 Q3 | 13.38 Million USD | 0.35% |
| 2018 Q2 | 13.33 Million USD | 37.09% |
| 2018 Q1 | 9.72 Million USD | -46.95% |
| 2018 FY | 10.47 Million USD | -42.89% |
| 2017 FY | 18.33 Million USD | 1570.13% |
| 2017 Q4 | 18.33 Million USD | -13.39% |
| 2017 Q3 | 21.17 Million USD | 538.54% |
| 2017 Q2 | 3.31 Million USD | -16.35% |
| 2017 Q1 | 3.96 Million USD | 261.02% |
| 2016 Q3 | 8.49 Million USD | -15.65% |
| 2016 Q4 | 1.09 Million USD | -87.08% |
| 2016 FY | 1.09 Million USD | -91.48% |
| 2016 Q1 | 11.36 Million USD | -11.79% |
| 2016 Q2 | 10.07 Million USD | -11.4% |
| 2015 Q3 | 12.12 Million USD | -9.44% |
| 2015 Q2 | 13.38 Million USD | -8.35% |
| 2015 FY | 12.88 Million USD | 136.42% |
| 2015 Q1 | 14.6 Million USD | 168.01% |
| 2015 Q4 | 12.88 Million USD | 6.28% |
| 2014 Q4 | 5.45 Million USD | -21.34% |
| 2014 Q3 | 6.93 Million USD | -16.89% |
| 2014 Q2 | 8.33 Million USD | -13.06% |
| 2014 Q1 | 9.59 Million USD | -12.12% |
| 2014 FY | 5.45 Million USD | -50.05% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 10.91 Million USD | -18.61% |
| 2013 Q4 | 10.91 Million USD | 0.0% |
| 2012 FY | 13.41 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 3.07 Million USD | -819.909% |
| Biodesix, Inc. | 35.22 Million USD | 19.722% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -2428.28% |
| Castle Biosciences, Inc. | 14.19 Million USD | -99.169% |
| DarioHealth Corp. | 24.59 Million USD | -14.993% |
| Exact Sciences Corporation | 2.47 Billion USD | 98.858% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 95.46% |
| Illumina, Inc. | 1.48 Billion USD | 98.101% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -34672.023% |
| iSpecimen Inc. | 29.13 Thousand USD | -96975.18% |
| Standard BioTools Inc. | 3.98 Million USD | -609.967% |
| 23andMe Holding Co. | 67.84 Million USD | 58.32% |
| Medpace Holdings, Inc. | 142.12 Million USD | 80.103% |
| NeoGenomics, Inc. | 606.06 Million USD | 95.334% |
| Inotiv, Inc. | 399.4 Million USD | 92.92% |
| Psychemedics Corporation | 945 Thousand USD | -2892.381% |
| Prenetics Global Limited | 867.21 Thousand USD | -3160.783% |
| Precipio, Inc. | 106 Thousand USD | -26577.358% |
| RadNet, Inc. | 812.06 Million USD | 96.518% |
| Sotera Health Company | 2.22 Billion USD | 98.728% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -2369.694% |
| Exagen Inc. | 19.23 Million USD | -47.044% |
| Natera, Inc. | 282.94 Million USD | 90.006% |
| Aspira Women's Health Inc. | 1.43 Million USD | -1877.483% |
| Neogen Corporation | 888.39 Million USD | 96.817% |
| Myriad Genetics, Inc. | 130.9 Million USD | 78.397% |
| ICON Public Limited Company | 3.66 Billion USD | 99.229% |
| Bionano Genomics, Inc. | 7.17 Million USD | -294.118% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 79.17 Million USD | 64.283% |
| Guardant Health, Inc. | 1.13 Billion USD | 97.519% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -28532.18% |
| Fulgent Genetics, Inc. | 10.11 Million USD | -179.676% |
| Sera Prognostics, Inc. | 840 Thousand USD | -3266.429% |
| OPKO Health, Inc. | 222.03 Million USD | 87.264% |
| Personalis, Inc. | 1.23 Million USD | -2191.572% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -3725.684% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -2369.694% |
| MDxHealth SA | 35.56 Million USD | 20.487% |
| Prenetics Global Limited | 867.21 Thousand USD | -3160.783% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -14623.371% |
| Mainz Biomed B.V. | 2.19 Million USD | -1187.77% |
| Trinity Biotech plc | 54.65 Million USD | 48.257% |
| Neuronetics, Inc. | 59.28 Million USD | 52.3% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -2428.28% |